US Biosimilars Market Revenue Size To Outreach USD 100.75 Billion By 2029 – CAGR 40.2%

The us biosimilars market size was estimated at USD 6.73 Billion in 2021. Fortune Business Insights predicts the Industry in terms of revenue is estimated to be worth USD 100.75 Billion by 2029 and is poised to grow at a CAGR of 40.2% during the forecast period (2022-2029). The report covers industry size, the latest trends, regional share, demand, recent developments and business opportunities. The report is titled, “US Biosimilars Market Analysis and Forecast, 2023- 2029”

Get a Free Sample Research PDF:

In-depth analysis focusing on the Industry trend ly, the us biosimilars market is examined until the year 2029. The primary goal of this report is to give readers a comprehensive picture of the Industry, including a breakdown of the industry by product/application and geography. During the projected time, there will be a significant increase in worldwide demand. In addition to offering important trends and opportunities in the Industry, the research report delivers critical statistics on the competitive landscape for the us biosimilars market.

Factors affecting the us biosimilars market:

  • Patent Expirations of Biologic Drugs
  • Regulatory Framework and Approval Process
  • Cost-effectiveness and Pricing Strategies
  • Physician and Patient Acceptance and Awareness
  • Competition from Originator Biologic Drugs

The most recent report by Fortune Business Insights identifies key opportunities for Industry development over the forecast period. This report plots Industry opportunities using a detailed analysis of the current us biosimilars market scenario, mergers & acquisitions, investments in research & development, technological developments, novel industry strategies, and buyers’ behaviour. The key opportunities covered in the report will provide a better understanding of the us biosimilars market and its future growth.

The following are the major objectives of the study

To define, describe, and forecast the us biosimilars market based on By Product, Technology, Application, End-user, and Region

  • To provide detailed information regarding the major factors influencing the growth of the Industry (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro Industries concerning individual growth trends, prospects, and contributions to the Industry
  • To analyze opportunities in the Industry for key stakeholders and provide details of the competitive landscape for the major Industry leaders
  • To forecast the size of the Industry segments concerning four major regions, namely, North America, Europe, Asia-Pacific,
  • To profile the key players in the Industry and comprehensively analyze their Industry shares and core competencies
  • To track and analyze competitive developments such as product launches, agreements, partnerships, & collaborations, mergers & acquisitions, research & development activities in the us biosimilars market

Speak to Analyst for Queries:

List of Key Players Covered in the Report:

  • Pfizer Inc. (U.S.)
  • Amgen Inc. (U.S.)
  • Samsung Bioepis (South Korea)
  • Novartis AG (Switzerland)
  • Celltrion Inc. (South Korea)
  • Viatris Inc.(U.S.)
  • Coherus BioSciences (U.S.)

The use of the us biosimilars market report can help investors to make more informed decisions, access a wider range of investment options, and achieve their financial goals more effectively. Additionally, the Industry for us biosimilars market is growing rapidly, driven by factors covered in the report. As a result, the Industry is expected to grow in the forecasted years.

Major Points in TOC:

  • US Biosimilars Market Overview and Scope
  • Sales Volume and CAGR
  • Total Consumption Region wise
  • Latest Industry Outlook
  • US Biosimilars Market Drivers Analysis
  • Emerging Trends
  • Revenue Forecast
  • Current Price and Gross Margin
  • Industry Dynamics, Risk and Challenges
  • Porter’s five forces analysis
  • Key developments (mergers, Acquisitions, etc.)
  • US Biosimilars Market Analysis, Insights and Forecast, 2029
  • End Users and Applications

TOC Continued……………

Quick Buy – US Biosimilars Market Report:


How Big is the US Biosimilars Market?

The US Biosimilars Market is estimated to be worth USD 100.75 Billion by 2029 and is poised to grow at a CAGR of 40.2% during (2022-2029)

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic Industry intelligence, giving a granular overview of the Industry they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive Industry studies, interspersed with relevant data.

At Fortune Business Insights, we aim to highlight our clients’ most lucrative growth opportunities. We, therefore, offer recommendations, making it easier for them to navigate through technological and Industry-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Email: [email protected]

Phone: US +1 424 253 0390 / UK +44 2071 939123 / APAC: +91 744 740 1245





 Trending Reports

Subperiosteal Dental Implants Market 2023 Size, Trends Outlook, Geographical Segmentation 2030

Traction Beds Market 2023 Size, Gross Margin, Trends, Future Demand, Analysis by Top Leading Players and Forecast till 2030

Non-rebreathing Oxygen Mask Market 2023 Key Drivers, Restraints, Industry Size & Share, Opportunities, Trends, and Forecasts up to 2030

Plasma Fractionation Market 2023 Key Drivers, Restraints, Industry Size & Share, Opportunities, Trends, and Forecasts up to 2030

Intraoperative Imaging Market 2023 Data Current and Future Trends, Industry Size, Share, Revenue, Business Growth Forecast to2030

Hormonal Contraceptives Market 2023 Latest Industry Size, Growth, Share, Demand, Trends, Competitive Landscape and Forecasts to 2030

Drug Eluting Stent Market 2023 Size, Trends Outlook, Geographical Segmentation 2030